Study Warns: 40 Million People Could Face Insulin Shortage by 2030

A new global health study has raised alarm over a looming insulin crisis, predicting that nearly 40 million people living with diabetes could be left without access to insulin by 2030.

The report highlights growing concerns about the rising global demand for insulin—a life-saving drug essential for people with type 1 and advanced type 2 diabetes—amid persistent supply chain challenges, high costs, and unequal distribution across regions.

According to researchers, low- and middle-income countries are expected to be hit hardest, as health systems in many parts of Africa, Asia, and Latin America continue to struggle with affordability and availability. The study calls for urgent international action to improve insulin production, lower prices, and ensure equitable access for all patients.

Health experts warn that without stronger policies and partnerships between governments, pharmaceutical companies, and global health organizations, millions could face severe health risks, including complications and preventable deaths.

The World Health Organization (WHO) and global diabetes advocates are urging countries to prioritize insulin access as part of universal health coverage goals, stressing that “no one with diabetes should die because they cannot afford or access insulin.”